CA15-3 serum levels in breast cancer and other malignancies ― correlation with clinical courseBARAK, V; CARLIN, D; SULKES, A et al.Israel journal of medical sciences. 1988, Vol 24, Num 9-10, pp 623-627, issn 0021-2180Article

La prescription du CA 15.3 dans la circonscription de la caisse primaire d'assurance maladie de Roubaix = The prescribing of CA 15.3 in the Roubaix districtCHRETIEN, P.Gynécologie obstétrique & fertilité. 2003, Vol 31, Num 5, pp 442-445, issn 1297-9589, 4 p.Article

Serum tumor marker CA 15.3 and stage are the two most powerful predictors of survival in primary breast cancerKUMPULAINEN, Eero Juha; KESKIKURU, Riitta Johanna; JOHANSSON, Risto Tapio et al.Breast cancer research and treatment. 2002, Vol 76, Num 2, pp 95-102, issn 0167-6806, 8 p.Article

Clinical evaluation comparing AxSYM® CA 15-3, IMx® CA 15-3 and truquant® BR RIALYNCHA, D. M; ROGERS, P. E; JONES, K. A et al.Tumor biology. 1998, Vol 19, Num 6, pp 421-438, issn 1010-4283Conference Paper

Prognostic value of CA 15.3 kinetics for metastatic breast cancerDE LA LANDE, B; HACENE, K; FLOIRAS, J.-L et al.The International journal of biological markers. 2002, Vol 17, Num 4, pp 231-238, issn 0393-6155, 8 p.Article

Performance characteristics of seven automated CA 15-3 assaysSLEV, Patricia R; RAWLINS, Mindy L; ROBERTS, William L et al.American journal of clinical pathology. 2006, Vol 125, Num 5, pp 752-757, issn 0002-9173, 6 p.Article

Role of preoperative plasma CA 15-3 and carcinoembryonic antigen levels in determining histopathologic conventional prognostic factors for breast cancerSEKER, Duray; KAYA, Oskay; ADABAG, Aysegul et al.World journal of surgery. 2003, Vol 27, Num 5, pp 519-521, issn 0364-2313, 3 p.Article

Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patientsPICHON, Marie-France; LE BRUN, Gaëlle; HACENE, Kamel et al.Clinical chemistry and laboratory medicine. 2009, Vol 47, Num 8, pp 985-992, issn 1434-6621, 8 p.Article

Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancerLEE, J. S; PARK, S; PARK, J. M et al.Annals of oncology. 2013, Vol 24, Num 5, pp 1225-1231, issn 0923-7534, 7 p.Article

Automated immunofluorometric assay for MUC1NORUM, Lars F; NILSSON, Olle; NUSTAD, Kjell et al.Tumor biology. 2001, Vol 22, Num 3, pp 169-175, issn 1010-4283Article

Tumor associated glycoprotein (TAG) 12 : A new tumor marker in breast cancerHEINZE, Thomas; LICHTENEGGER, Werner.Anticancer research. 2000, Vol 20, Num 6D, pp 5049-5052, issn 0250-7005Article

Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cyclesBON, G. G; KENEMANS, P; DEKKER, J. J et al.Human reproduction (Oxford. Print). 1999, Vol 14, Num 2, pp 566-570, issn 0268-1161Article

Predictive value of CEA and CA 15-3 in the follow up of invasive breast cancerSÜTTERLIN, M; BUSSEN, S; TROTT, S et al.Anticancer research. 1999, Vol 19, Num 4A, pp 2567-2570, issn 0250-7005Conference Paper

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patientsTAMPELLINI, Marco; BERRUTI, Alfredo; DURANDO, Antonio et al.Breast cancer research and treatment. 2006, Vol 98, Num 3, pp 241-248, issn 0167-6806, 8 p.Article

Que reste-t-il du bilan d'extension systématique ? : Le CA 15-3: quel intérêt dans le bilan d'extension systématique ? = CA 15-3 : which interest in the staging assessment of primary breast cancer?DALENC, F.Société française de sénologie et de pathologie mammaire. 2006, pp 314-319, isbn 2-915968-10-1, 1Vol, 6 p.Conference Paper

Prognostic significance of Serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancerFEHM, Tanja; JÄGER, Wolfram; KRÄMER, Stefan et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1987-1992, issn 0250-7005, 6 p.Article

Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancerGION, M; MIONE, R; LEON, A. E et al.Clinical chemistry (Baltimore, Md.). 1999, Vol 45, Num 5, pp 630-637, issn 0009-9147Conference Paper

Influence de la concentration sérique de CA 15-3 sur les performances diagnostiques de la TEP FDG chez patientes ayant un cancer du sein avec imagerie négativeAIDE, N; SWITSERS, O; ALLOUACHE, D et al.Société française de sénologie et de pathologie mammaire. Journées. 2007, pp 67-68, isbn 978-2-287-72614-9, 1Vol, 2 p.Conference Paper

Comparability of eight immunoassay procedures for the determination of CA 15-3 and related markers : Vitamins and trace elements: The distance between deficiency and repletion and between care and preventionSTERN, Petr; BARTOS, Vladimir; VAVROVA, Jaroslava et al.Clinical chemistry and laboratory medicine. 2003, Vol 41, Num 8, pp 1087-1094, issn 1434-6621, 8 p.Article

Serum CEA and CA 15-3 as prognostic factors in primary breast cancerEBELING, F. G; STIEBER, P; UNTCH, M et al.British journal of cancer. 2002, Vol 86, Num 8, pp 1217-1222, issn 0007-0920Article

Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer : Comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA)GIOVANELLA, Luca; CERIANI, Luca; GIARDINA, Giovanni et al.Clinical chemistry and laboratory medicine. 2002, Vol 40, Num 3, pp 298-303, issn 1434-6621Article

Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinomaSHERING, S. G; SHERRY, F; MCDERMOTT, E. W et al.Cancer. 1998, Vol 83, Num 12, pp 2521-2527, issn 0008-543XArticle

Circulating CA 15-3 antigen levels in non-mammary malignanciesCOLOMER, R; RUIBAL, A; GENOLLA, J et al.British journal of cancer. 1989, Vol 59, Num 2, pp 283-286, issn 0007-0920Article

Development of an Au/ZnO thin film surface plasmon resonance-based biosensor immunoassay for the detection of carbohydrate antigen 15-3 in human salivaLIANG, Yang-Hung; CHANG, Chia-Chen; CHEN, Chien-Cheng et al.Clinical biochemistry. 2012, Vol 45, Num 18, pp 1689-1693, issn 0009-9120, 5 p.Article

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomesPARK, B.-W; OH, J.-W; KIM, J.-H et al.Annals of oncology. 2008, Vol 19, Num 4, pp 675-681, issn 0923-7534, 7 p.Article